Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Update on thyroid-associated Ophthalmopathy with a special emphasis on the ocular surface.

Novaes P, Diniz Grisolia AB, Smith TJ.

Clin Diabetes Endocrinol. 2016 Nov 16;2:19. doi: 10.1186/s40842-016-0037-5. eCollection 2016. Review.

2.

Simultaneous induction of Graves' hyperthyroidism and Graves' ophthalmopathy by TSHR genetic immunization in BALB/c mice.

Xia N, Ye X, Hu X, Song S, Xu H, Niu M, Wang H, Wang J.

PLoS One. 2017 Mar 20;12(3):e0174260. doi: 10.1371/journal.pone.0174260. eCollection 2017.

3.
4.

New developments in peritoneal fibroblast biology: implications for inflammation and fibrosis in peritoneal dialysis.

Witowski J, Kawka E, Rudolf A, Jörres A.

Biomed Res Int. 2015;2015:134708. doi: 10.1155/2015/134708. Epub 2015 Oct 1. Review.

5.

Graves' Ophthalmopathy: VISA versus EUGOGO Classification, Assessment, and Management.

Barrio-Barrio J, Sabater AL, Bonet-Farriol E, Velázquez-Villoria Á, Galofré JC.

J Ophthalmol. 2015;2015:249125. doi: 10.1155/2015/249125. Epub 2015 Aug 17. Review.

6.

Site-specific mesenchymal control of inflammatory pain to yeast challenge in vulvodynia-afflicted and pain-free women.

Foster DC, Falsetta ML, Woeller CF, Pollock SJ, Song K, Bonham A, Haidaris CG, Stodgell CJ, Messing SP, Iadarola M, Phipps RP.

Pain. 2015 Mar;156(3):386-96. doi: 10.1097/01.j.pain.0000460320.95267.5d.

7.

TSH-receptor-expressing fibrocytes and thyroid-associated ophthalmopathy.

Smith TJ.

Nat Rev Endocrinol. 2015 Mar;11(3):171-81. doi: 10.1038/nrendo.2014.226. Epub 2015 Jan 6. Review.

8.

PI3K/AKT pathway mediates induction of IL-1RA by TSH in fibrocytes: modulation by PTEN.

Li B, Smith TJ.

J Clin Endocrinol Metab. 2014 Sep;99(9):3363-72. doi: 10.1210/jc.2014-1257. Epub 2014 May 19.

9.

Independent adipogenic and contractile properties of fibroblasts in Graves' orbitopathy: an in vitro model for the evaluation of treatments.

Li H, Fitchett C, Kozdon K, Jayaram H, Rose GE, Bailly M, Ezra DG.

PLoS One. 2014 Apr 21;9(4):e95586. doi: 10.1371/journal.pone.0095586. eCollection 2014.

10.

Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.

Wang Y, Smith TJ.

Invest Ophthalmol Vis Sci. 2014 Mar 20;55(3):1735-48. doi: 10.1167/iovs.14-14002. Review.

11.

Human fibrocytes express multiple antigens associated with autoimmune endocrine diseases.

Fernando R, Vonberg A, Atkins SJ, Pietropaolo S, Pietropaolo M, Smith TJ.

J Clin Endocrinol Metab. 2014 May;99(5):E796-803. doi: 10.1210/jc.2013-3072. Epub 2014 Feb 11.

12.

Orbital fibroblasts from thyroid eye disease patients differ in proliferative and adipogenic responses depending on disease subtype.

Kuriyan AE, Woeller CF, O'Loughlin CW, Phipps RP, Feldon SE.

Invest Ophthalmol Vis Sci. 2013 Nov 8;54(12):7370-7. doi: 10.1167/iovs.13-12741.

13.

Effects of prostaglandin F(2α) on adipocyte biology relevant to graves' orbitopathy.

Draman MS, Grennan-Jones F, Zhang L, Taylor PN, Tun TK, McDermott J, Moriarty P, Morris D, Lane C, Sreenan S, Dayan C, Ludgate M.

Thyroid. 2013 Dec;23(12):1600-8. doi: 10.1089/thy.2013.0194. Epub 2013 Nov 4.

14.

Thyroid-associated orbitopathy: Current insights into the pathophysiology, immunology and management.

Bhatt R, Nelson CC, Douglas RS.

Saudi J Ophthalmol. 2011 Jan;25(1):15-20. doi: 10.1016/j.sjopt.2010.11.002. Epub 2010 Nov 11.

15.
16.

Interleukin-6 production in CD40-engaged fibrocytes in thyroid-associated ophthalmopathy: involvement of Akt and NF-κB.

Gillespie EF, Raychaudhuri N, Papageorgiou KI, Atkins SJ, Lu Y, Charara LK, Mester T, Smith TJ, Douglas RS.

Invest Ophthalmol Vis Sci. 2012 Nov 21;53(12):7746-53. doi: 10.1167/iovs.12-9861.

17.

Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves' orbitopathy.

Smith TJ, Hegedüs L, Douglas RS.

Best Pract Res Clin Endocrinol Metab. 2012 Jun;26(3):291-302. doi: 10.1016/j.beem.2011.10.002. Review.

18.

Immunopathogenesis of Graves' ophthalmopathy: the role of the TSH receptor.

Iyer S, Bahn R.

Best Pract Res Clin Endocrinol Metab. 2012 Jun;26(3):281-9. doi: 10.1016/j.beem.2011.10.003. Review.

19.

Human fibrocytes coexpress thyroglobulin and thyrotropin receptor.

Fernando R, Atkins S, Raychaudhuri N, Lu Y, Li B, Douglas RS, Smith TJ.

Proc Natl Acad Sci U S A. 2012 May 8;109(19):7427-32. doi: 10.1073/pnas.1202064109. Epub 2012 Apr 19.

20.

Nuclear targeting of IGF-1 receptor in orbital fibroblasts from Graves' disease: apparent role of ADAM17.

Hoa N, Tsui S, Afifiyan NF, Sinha Hikim A, Li B, Douglas RS, Smith TJ.

PLoS One. 2012;7(4):e34173. doi: 10.1371/journal.pone.0034173. Epub 2012 Apr 10.

Supplemental Content

Support Center